Biotech · Private company
TKL Research, Inc.
Track this companyFree. Adds TKL Research, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- Study to Evaluate HT-6184 in Healthy SubjectsPHASE1 · COMPLETED · started Jun 15, 2022ClinicalTrials.gov NCT05447546 · fetched Nov 12, 2026
- A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal SystemPHASE4 · COMPLETED · started Oct 25, 2021ClinicalTrials.gov NCT07739589 · fetched Nov 12, 2026
- Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic KeratosisPHASE1 · COMPLETED · started Sep 7, 2018ClinicalTrials.gov NCT03575780 · fetched Nov 12, 2026
- A 21 Day Irritation Study in Healthy Volunteers With Diacerein 1% OintmentPHASE1 · COMPLETED · started Jan 9, 2018ClinicalTrials.gov NCT03472534 · fetched Nov 12, 2026
- Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir LotionPHASE1 · COMPLETED · started Jan 1, 2014ClinicalTrials.gov NCT02062073 · fetched Nov 12, 2026
- Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid RecurrencePHASE2 · TERMINATED · started Jun 1, 2009ClinicalTrials.gov NCT00987545 · fetched Nov 12, 2026